This analysis, which captures data on 3434 somatic PTEN alterations identified in tumors, allows us to assign specific patterns of mutations as a consequence of tumor subsite, age, sex, MSI-H/MSS status, tumor mutation burden (TMB), and co-segregation with other driver mutations. Here, PTEN is linked to neoplasm.